Predictive value of adiponectin to prognosis in patients with acute myocardial infarction after emergency percutaneous coronary intervention
CHEN Jia-wei
WANG Yong-liang
LIU Shou-lian
CHEN Yue-ting
WANG Guo-long
Abstract：Objective To discuss the predictive value of adiponectin to prognosis in patients with acute myocardial infarction (AMI) after emergency percutaneous coronary intervention (PCI). Methods The patients (n=206) with the first time AMI were chosen from July 2010 to Aug. 2011, and divided, according to level of adiponectin, into high adiponectin group and low adiponectin group. The left ventricular end-diastolic inner diameter (LVEDd) and left ventricular ejection fraction (LVEF) were calculated. The severity of coronary artery lesion and coronary flow were reviewed after coronary angiography (CAG). All patients were followed up averagely for 6 m for observing mortality and incidence of major adverse cardiovascular events (MACE). Results ①The levels of hospitalized immediate plasma glucose and fasting plasma glucose were significantly higher in low adiponectin group than those in high adiponectin group (P<0.05). The corrected TIMI frame count was significantly lower in high adiponectin group than that in low adiponectin group (P<0.05). ②The hospitalized mortality had no significant difference between 2 group (P>0.05), and incidence of MACE was higher in low adiponectin group than that in high adiponectin group (P<0.05). Conclusion Adiponectin has the predictive value to prognosis in patients with AMI after emergency PCI during hospitalization and follow-up period.
Keywords：AdiponectinAcute myocardial infarctionMajor adverse cardiovascular events
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 121-125 )